Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Novabay Pharmaceuticals (NBY)

1.01   0.054 (5.65%) 08-13 16:00
Open: 0.95 Pre. Close: 0.956
High: 1.04 Low: 0.925
Volume: 1,524,926 Market Cap: 42M
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products to address therapeutic needs of the anti-infective market in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, including the eyelid; CelleRx for the aesthetic dermatology market; and NeutroPhase for the wound care market. It also develops auriclosene, a synthetic molecule for use against bacteria, viruses, and fungi. The company has a collaboration and license agreement with Virbac to develop auriclosene for veterinary markets for companion animals. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.042 - 1.049 1.049 - 1.056
Low: 0.914 - 0.922 0.922 - 0.93
Close: 0.997 - 1.01 1.01 - 1.023

Technical analysis

as of: 2020-08-13 4:36:37 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.81     One year: 2.27
Support: Support1: 0.92    Support2: 0.77
Resistance: Resistance1: 1.55    Resistance2: 1.94
Pivot: 1.18
Moving Average: MA(5): 1.05     MA(20): 1.23
MA(100):     MA(250): 0.76
MACD: MACD(12,26): -0.03     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 9.82     %D(3): 8.31
RSI: RSI(14): 41.29
52-week: High: 1.94  Low: 0.24  Change(%): 40.3
Average Vol(K): 3-Month: 546946  10-Days: 331310

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
NBY has closed above bottom band by 17.3%. Bollinger Bands are 7.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 13 Aug 2020
Why Do Investors Care About NovaBay Pharmaceuticals, Inc. (NBY) - The News Heater

Sun, 09 Aug 2020
NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

Thu, 06 Aug 2020
NovaBay Pharmaceuticals Reports Second Quarter 2020 Financial Results - Yahoo Finance

Thu, 06 Aug 2020
Are Shares Of NovaBay Pharmaceuticals, Inc. (NBY) Really Worth? - Invest Million

Mon, 03 Aug 2020
Gear up for the change! NovaBay Pharmaceuticals Inc. (NBY) has hit the volume of 1392532 - The InvestChronicle

Wed, 29 Jul 2020
NovaBay Pharmaceuticals Inc. (NBY) is heading in the right direction with an average volume of $5.31M - News Daemon

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 33
Shares Float (M) 17
% Held by Insiders 41.27
% Held by Institutions 6.53
Shares Short (K) 249
Shares Short P. Month (K) 377

Stock Financials

EPS -0.323
EPS Est This Year -0.470
EPS Est Next Year -0.090
Book Value (p.s.) -0.010
Profit Margin -100.14
Operating Margin -93.82
Return on Assets (ttm) -43.0
Return on Equity (ttm) -1807.9
Qtrly Rev. Growth 30.5
Gross Profit (p.s.) 0.146
Sales Per Share 0.211
EBITDA (p.s.) -0.196
Qtrly Earnings Growth
Operating Cash Flow (M) -6
Levered Free Cash Flow (M) -2

Stock Valuations

PE Ratio -3.13
PEG Ratio
Price to Book value -101.00
Price to Sales 4.79
Price to Cash Flow -6.05

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.